Back to M&A

Merger and Acquisition

AT4 secures 20% Kilba tungsten offtake right and subscribes for Mammoth Minerals shares

American Tungsten & Antimony (ASX: AT4)16 November 2026

Headline consideration

A$1,577,333

60,666,666 Mammoth shares at A$0.026 per share

Interest acquired

Approximately 8.6% of Mammoth

On completion of both tranches and Mammoth’s broader placement

Mineral resource

7.2Mt at 0.19% WO₃

13,800t contained WO₃, JORC 2012, as reported by Mammoth

Summary

American Tungsten & Antimony Ltd (ASX: AT4) has signed a Binding Framework Agreement with Mammoth Minerals Limited (ASX: M79) covering a strategic investment, an exclusive tungsten offtake right and a joint work program. AT4 will subscribe for a total of 60,666,666 fully paid ordinary shares in Mammoth at A$0.026 per share, a total of A$1,577,333. Mammoth has granted AT4 the exclusive right to purchase 20% of all tungsten concentrate and other tungsten-bearing product produced from within the current Kilba Mineral Resource in Western Australia, to be processed into ammonium paratungstate (APT) at AT4’s Del Sol Refinery in Nevada. The company states the right is to be documented in a binding Offtake Agreement, and that AT4 is not obliged to enter into it.

Consideration

ComponentTerms
Share subscription60,666,666 fully paid ordinary Mammoth shares at A$0.026 per share, total A$1,577,333
Tranche 140,000,000 shares at A$0.026 (A$1,040,000), issued under Mammoth’s Listing Rule 7.1 placement capacity
Tranche 220,666,666 shares at A$0.026 (A$537,333), subject to Mammoth shareholder approval
ShareholdingApproximately 8.6% of Mammoth on completion of both tranches and Mammoth’s broader placement, before the issue of Kilba acquisition consideration shares
Shareholding limitAT4 will not move to 10% or more of Mammoth before the Offtake Agreement is signed and any Mammoth shareholder approval required under Listing Rule 10.1 is obtained
Use of fundsDue diligence on Kilba and the cash consideration for the Kilba acquisition, with not less than 70% applied to Kilba
FundingThe investment will be funded from AT4’s existing cash reserves
Offtake rightExclusive right to purchase 20% of all tungsten concentrate and other tungsten-bearing product from the current Kilba Mineral Resource, measured by contained WO₃, until depleted; extension to future Mineral Resources by agreement
Pricing principlesTo be negotiated; APT-linked concentrate pricing, with payability and penalties in line with industry practice; refining margin retained by AT4
Offtake AgreementTo be negotiated in good faith, targeting signing within 3 months after the Investigation Report is approved; AT4 may require signing within 40 business days, with terms not agreed determined by an independent expert
Step-in rightIf the Kilba acquisition agreement terminates or does not complete in time, AT4 may require Mammoth to transfer M79 WA Pty Ltd, or assign its rights under the acquisition agreement, to AT4 for the amounts paid by M79 WA Pty Ltd under that agreement
CostsEach party bears its own costs; Mammoth funds bulk sampling and beneficiation testwork; AT4 funds hydrometallurgical testwork at Del Sol and the extension of its APT concept study
TerminationThe offtake right lapses if no Offtake Agreement is signed within 18 months, unless AT4 has called for the Offtake Agreement; the placement funds are not refundable on termination
Liability capsMammoth’s liability capped at A$1.3 million and AT4’s at A$0.5 million, excluding the subscription amount

Conditions

  • Tranche 1 is conditional on the Agreement being signed and Mammoth’s announcement of the transaction
  • Tranche 2 is subject to Mammoth shareholder approval at a general meeting to be held within 3 months, and to the Agreement and the Kilba acquisition agreement remaining on foot
  • Implementation of the offtake is subject to AT4 being satisfied with its due diligence
  • Implementation of the offtake is subject to the Kilba tenure being granted and remaining in good standing
  • Implementation of the offtake is subject to negotiation and signing of the Offtake Agreement
  • Implementation of the offtake is subject to any required shareholder and regulatory approvals and other customary conditions

Timetable

22 April 2027Mammoth must use best endeavours to complete the Kilba acquisition by this date

Project snapshot

ItemDetail
Mineral Resource (total)7.2Mt at 0.19% WO₃ for 13,800t of contained WO₃, JORC 2012, at a 0.05% WO₃ cut-off, as reported by Mammoth in its ASX announcement dated 16 November 2026
Indicated5,700 at 0.20% WO₃ for 11,600 contained WO₃ (t); 79% Indicated by tonnage
Inferred1,460 at 0.15% WO₃ for 2,200 contained WO₃ (t)

Source: American Tungsten & Antimony announcement dated 16 November 2026. This page summarises information from the company's public announcement and is provided for general information only. It is not financial product advice, a recommendation or an offer, and it does not take into account any person's objectives, financial situation or needs. Figures and terms are taken from the announcement and may be incomplete or may have changed since publication. Refer to the original announcement for full details. Kamoa Capital has not independently verified the information.

More from American Tungsten & Antimony

Latest mining M&A deals

Explore